Scarica l'app Stockscreener
3.28
6.02%
-0.21
Aclaris Therapeutics Inc Azioni (ACRS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
18.39%
1.629
|
1.996 | 1.295 | 3.299 | 1.777 |
| Cost Of Revenue |
44.81%
0.218
|
0.395 | 0.532 | 0.538 | 0.515 |
| Research and Development |
15.39%
18.07
|
15.66 | - | - | - |
| Costs And Expenses |
6.94%
25.87
|
24.19 | 24.03 | 20.45 | 20.18 |
| Operating Income/Loss |
9.22%
-24.24
|
-22.19 | -22.73 | -17.15 | -18.41 |
| Nonoperating Income/Loss |
15.41%
2.733
|
2.368 | 2.939 | 2.535 | 2.979 |
| Net Income/Loss |
8.48%
-21.50
|
-19.82 | -19.80 | -14.61 | -15.43 |
| Basic Average Shares |
10.81%
142.74
|
128.81 | 0.0337 | 122.62 | 122.58 |
| Diluted Average Shares |
10.81%
142.74
|
128.81 | 0.0337 | 122.62 | 122.58 |
| Basic Earnings Per Share |
0.00%
-0.15
|
-0.15 | -0.16 | -0.12 | -0.13 |
| Diluted Earnings Per Share |
0.00%
-0.15
|
-0.15 | -0.16 | -0.12 | -0.13 |
4.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):